Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Rev. bras. cir. plást ; 34(4): 531-538, oct.-dec. 2019. ilus, tab
Article in English, Portuguese | LILACS | ID: biblio-1047921


O linfoma anaplásico de grandes células associado ao implante de mama (Breast Implant Associated Anaplastic Large Cell Lymphoma - BIA-ALCL) é uma doença maligna recentemente descoberta, rara e possivelmente associada aos implantes mamários texturizados. Essa revisão da literatura teve como objetivo trazer novas atualizações acerca da epidemiologia, fisiopatologia e fatores de risco para desenvolvimento do BIAALCL. Foi realizado o levantamento de dados do período de dezembro de 2018 a fevereiro de 2019, através das bases de dados PUBMED, LILACS e Scielo sendo selecionados 10 artigos publicados entre 2016 e 2018. Foi encontrada uma incidência variando entre 2,8:100.000 a 1:3 milhões de pacientes com implantes mamários. Os dados coletados corroboram para a teoria de que não há uma relação direta de causa e efeito entre os implantes mamários, mormente os texturizados, e o desenvolvimento do BIA-ALCL, podendo esses ser considerados somente como fatores de risco e não agentes causadores. A teoria fisiopatológica mais aceita é a de que os implantes mamários com maior área de superfície levariam a formação de maior biofilme por maior adesão bacteriana gerando inflamação crônica mais proeminente, levando ao gatilho para a transformação maligna das células T. As informações explicitadas nessa revisão devem auxiliar na ampliação de estudos acerca da doença e criação de políticas públicas para a prevenção e diagnóstico precoce de tal enfermidade. Pelos dados encontrados há necessidade de que cirurgiões plásticos realizem acompanhamento mais próximo de seus pacientes, assim como orientem os pacientes antes das cirurgias sobre a existência da doença.

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a newly discovered and rare cancer possibly associated with textured breast implants. This literature review investigates its epidemiology, pathophysiology, and risk factors. PubMed, LILACS, and SciELO databases were searched from December 2018 to February 2019, and 10 articles published between 2016 and 2018 were selected. The incidence of BIA-ALCL ranged from 2.8:100,000 to 1:3 million breast implants. The obtained data corroborate the hypothesis that there is no direct cause and effect relationship between breast implants, especially textured implants, and BIA-ALCL, and these implants can be considered risk factors but not causative factors. The most accepted hypothesis on disease pathophysiology is that breast implants with larger surface areas may promote bacterial adhesion and biofilm formation, leading to severe chronic inflammation, triggering the malignant transformation of T cells. This review provides knowledge on BIA-ALCL and helps develop and implement public policies for disease prevention and timely diagnosis. The data highlight that long-term follow up is necessary and that surgeons should advise patients of the potential risk of developing BIA-ALCL before performing the implant surgery.

Humans , History, 21st Century , Lymphoma, Non-Hodgkin , Breast Neoplasms , Lymphoma, T-Cell , Review , Lymphoma, Large-Cell, Anaplastic , Breast Implants , Breast Neoplasms/physiopathology , Hodgkin Disease/physiopathology , Lymphoma, T-Cell/physiopathology , Lymphoma, Large-Cell, Anaplastic/surgery , Lymphoma, Large-Cell, Anaplastic/physiopathology , Breast Implants/statistics & numerical data
Article in English | IMSEAR | ID: sea-40930


Epstein-Barr virus (EBV) is associated with several malignancies including nasopharyngeal carcinoma and lymphoma in immunocompromised patients. Quantitative monitoring of EBV DNA in these patients has recently become essential for management of the disease. In the present study the authors developed a rapid and reliable real-time PCR to quantify the EBV DNA in peripheral blood mononuclear cell (PBMC) using hybridization probe technique. The real-time primers and probes in this real-time PCR system were designed based on EBNA-1 sequence. The newly-established real-time PCR demonstrated its high sensitivity (as few as 10 copies of EBV could be detected) and specificity. The intra- and inter-assay variations of the assay were shown to be within a 0.5-log10-difference range. A total of 2 EBV-seronegative, 14 EBV-seropositive healthy donors and 4 patients with PCNSL were enrolled into the study. Our results revealed the median of EBV-DNA in lymphoma patients (7886 copies/10(6) PBMC or 15,150 copies /microg DNA) was higher than that of healthy donors (<10 copies/l0(6) PBMC or <10 copies/microg DNA) with statistic significance (P < 0.01). Assessment of this assay in larger number of donors and patients will provide clinical cut-off values which are essential for monitoring and diagnosis of EBV-associated diseases.

Adult , Blood Donors , Case-Control Studies , Computer Systems , DNA, Viral/analysis , Epstein-Barr Virus Infections/complications , Female , Herpesvirus 4, Human/isolation & purification , Humans , Lymphoma, T-Cell/physiopathology , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction/methods , Time Factors
Article in English | IMSEAR | ID: sea-39664


BACKGROUND: High frequency of Epstein-Barr virus (EBV) in the normal mucosa of the upper aerodigestive tract suggests that it may serve as a reservoir for the virus. Malignant lymphomas arising in this site may be associated with EBV. OBJECTIVES: To determine the prevalence of EBV infection in extranodal malignant lymphomas of the upper aerodigestive tract. SETTING: King Chulalongkorn Memorial Hospital, Thailand. DESIGN: Descriptive study. PATIENTS: 42 Thai patients who presented between 1998 and 2003. MATERIAL AND METHOD: The expression of EBV mRNAs (EBERs) of malignant lymphoma was studied by means of in situ hybridization in formalin-fixed, paraffin-embedded specimens. RESULTS: The recruited subjects were 26 males and 16 females, and their age ranged from 3 to 85 years with the mean of 51.43 years, in 4 of them human immune deficiency virus (HIV) infection was documented. Ten of 42 cases (23.81%) expressed EBER transcripts and were extranodal NK/T-cell lymphomas, nasal type (7 cases), plasmablastic lymphomas (2 cases) and diffuse large B-cell lymphoma (1 case). Three of 4 cases (75%) of known HIV-seropositive cases were EBV-positive (2 plasmablastic lymphomas and 1 diffuse large B-cell lymphoma). CONCLUSION: In the upper aerodigestive tract, EBV was present in some but not all malignant lymphoma. It was associated with extranodal NK/T-cell lymphoma, nasal type and B-cell lymphoma arising in HIV-infected patients, but it was not found in B-cell lymphoma arising in immunocompetent patients.

Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Disease Reservoirs , Epstein-Barr Virus Infections/epidemiology , Female , Herpesvirus 4, Human/isolation & purification , Humans , In Situ Hybridization , Lymphoma/physiopathology , Lymphoma, B-Cell/physiopathology , Lymphoma, T-Cell/physiopathology , Male , Middle Aged , Prevalence , Respiratory System/physiopathology , Risk Factors , Thailand/epidemiology , Upper Gastrointestinal Tract/physiopathology
Rev. méd. Hosp. Gen. Méx ; 61(1): 41-6, ene.-mar. 1998. ilus
Article in Spanish | LILACS | ID: lil-240934


Los linfomas primarios del intestino delgado son tumores raros, ocupan del 20 al 40 por ciento de las neoplasias malignas de esa región. Son un grupo heterogéneo de tumores con características clínicas y patológicas variables. Son neoplasias de adultos, se presentan con mayor frecuencia de los 20 a los 60 años. Los síntomas se desarrollan insidiosamente y pueden incluir pérdida de peso, diarrea, sangrado rectal, dolor abdominal, vómito y constipación. La enfermedad celiaca, la enfermedad inflamatoria intestinal y los estados de inmunodeficiencia se consideran factores predisponentes. El comportamiento biológico, el cuadro clínico, la morfología, el inmunofenotipo y el tratamiento son diferentes de los de los linfomas originados en ganglios linfáticos. Para clasificarlos correctamente es necesario definir el tipo histológico, el grado histológico, la resecabilidad del tumor y si se logra o no la remisión después del tratamiento combinado

Humans , Male , Female , Child, Preschool , Adolescent , Adult , Middle Aged , Burkitt Lymphoma/pathology , Burkitt Lymphoma/physiopathology , Burkitt Lymphoma/therapy , Immunoproliferative Small Intestinal Disease/pathology , Intestinal Neoplasms/diagnosis , Intestinal Neoplasms/pathology , Intestinal Neoplasms/physiopathology , Intestinal Neoplasms/therapy , Intestine, Small/pathology , Lymphoma, B-Cell/pathology , Lymphoma, B-Cell/physiopathology , Lymphoma, T-Cell/pathology , Lymphoma, T-Cell/physiopathology , Lymphoma, T-Cell/therapy , Lymphoma/classification , Neoplasm Staging/adverse effects , Prognosis , Survivors
Article in English | WPRIM | ID: wpr-181133


Intravascular lymphomatosis (IL) is a rare and generally fatal disease characterized by proliferation of large lymphoma cells almost exclusively within the lumen of small blood vessels. The skin and central nervous systems are typically affected, but involvement of other organs, such as lung, has been described. Predominant lung involvement without cutaneous and neurologic manifestation is very rare and difficult to diagnose. Originally considered as an endothelial disorder, IL has recently been reclassified as lymphoma. Most of the cases reported are of B cell lineage with a few cases of T cell type. We describe a case of the T-cell type IL manifested clinically as an interstitial lung disease without involvement of skin and central nervous systems. Immunohistochemical studies showed the T-cell nature of the neoplastic cells in open lung biopsy sample.

Blood Vessels/pathology , Diagnosis, Differential , Fatal Outcome , Humans , Lung Diseases, Interstitial/pathology , Lymphoma, T-Cell/physiopathology , Lymphoma, T-Cell/pathology , Lymphoma, T-Cell/immunology , Male , Middle Aged , Tomography Scanners, X-Ray Computed
Bol. Soc. Bras. Hematol. Hemoter ; 17(168): 15-8, jan.-abr. 1995.
Article in English | LILACS | ID: lil-194645


There are few reports in the world medical literature concerning association between leprosy and malignant lymphoma. It seams that, although defects in immune system related to leprosy are multiple and complex, no increase in incidence of malignant lymphoma among leprosy patients can be detected. This is also true for Brazil, where leprosy is an endemic disease, which poses an important public health problem. For this reason, the authors report on three cases of malignant lymphoma: one low grade, B-cell lymphoma (immunocytoma): one high grade, T-cell lymphoma and one mixed cellularity Hodgkin's disease in patients previously diagnosed as having leprosy.

Humans , Male , Adult , Middle Aged , Leprosy/complications , Lymphoma/complications , Hodgkin Disease/complications , Hodgkin Disease/physiopathology , Leprosy/physiopathology , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/physiopathology , Lymphoma, T-Cell/complications , Lymphoma, T-Cell/physiopathology , Lymphoma/physiopathology